Deepak Sapra
Fortuna: 1 M $ al 31/05/2026
Fortuna: 1 M $ al 31/05/2026
Deepak Sapra is currently the Chief Executive Officer-API & Services at Dr. Reddy's Laboratories Ltd. since 2003.
He is also a Director at Aurigene Pharmaceutical Services Ltd. Mr. Sapra was previously the Head-Custom Pharma Services Unit at Indian Institute of Management Bangalore.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2026 | 75.624 ( 0,01 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DR. REDDY'S LABORATORIES LIMITED | Corporate Officer/Principal | 01/01/2003 |
Aurigene Pharmaceutical Services Ltd.
Aurigene Pharmaceutical Services Ltd. BiotechnologyHealth Technology Engages in research and development of novel therapeutics for the treatment of cancer and inflammation | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Indian Institute of Management Bangalore
Indian Institute of Management Bangalore Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Dr. Reddy's Laboratories Ltd.
Dr. Reddy's Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Health Technology |
Indian Institute of Management Bangalore
Indian Institute of Management Bangalore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aurigene Pharmaceutical Services Ltd.
Aurigene Pharmaceutical Services Ltd. BiotechnologyHealth Technology Engages in research and development of novel therapeutics for the treatment of cancer and inflammation | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.